Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo

单克隆抗体 体内 胰腺癌 吉西他滨 细胞凋亡 抗体 流式细胞术 医学 体外 MUC1号 MTT法 药理学 分子生物学 癌症 癌症研究 抗原 免疫学 内科学 化学 生物 生物化学 生物技术
作者
Lin Zhang,Yanhong Hou,William P. Meehan,Haorun Liu,Yujing Wang
出处
期刊:Arab Journal of Gastroenterology [Elsevier BV]
卷期号:23 (4): 263-269 被引量:3
标识
DOI:10.1016/j.ajg.2022.06.005
摘要

This study was designed to compare the antitumor effects of anti-human MUC1 monoclonal antibody with those of anti-human CA199 monoclonal antibody coupled with drug-loaded polybutylcyanoacrylate nanoparticles on human pancreatic cancer cell lines and pancreatic cancer-bearing model animals and to screen more efficient targeting molecules.Gemcitabine-loaded nanospheres were prepared by emulsion polymerization (GEM-PBCA-NP), and then, anti-MUC1 monoclonal antibody was coupled with GEM-PBCA-NP (MUC1-GEM-PBCA-NP), and anti-human CA199 monoclonal antibody was coupled with GEM-PBCA-NP (CA199-GEM-PBCA-NP), using the chemical crosslinking method. The cell-killing rates were detected using MTT assay. The changes in the tumor cell cycle and apoptosis after treatment were detected using flow cytometry. Then, the subcutaneous planting method was adopted to establish an animal model of pancreatic cancer: two nanometer microspheres were injected into the body of nude mice via the tail vein; the tumor suppression effect was detected after treatment; then, the groups were compared.In vitro, the cell-killing rate of each experimental group was significantly different from that of the control group (P < 05). The MUC1-GEM-PBCA-NP group had a significantly higher cell-killing rate than the other groups (P < 05). The apoptosis rate of the MUC1-GEM-PBCA-NP treatment group was significantly higher than that of other groups (P < 05). In vivo, the tumor inhibition rate of the MUC1-GEM-PBCA-NP treatment group was 72.69% ± 4.29%, which was significantly higher than those of other groups (P < 0.05). The tumor inhibition rate of the CA199-GEM-PBCA-NP treatment group was 56.58% ± 5.11%, which was significantly higher than those of other control groups (P < 0.05). At the end of treatment, the average tumor mass of the MUC1-GEM-PBCA-NP treatment group was 433.55 ± 12.49 mg, which was significantly lower than those of other groups (P < 0.05).Compared with CA199-GEM-PBCA-NP, MUC1-GEM-PBCA-NP is more effective in vitro and in vivo. MUC1 could be a target molecule in treating pancreatic cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏应助luoshikun采纳,获得10
1秒前
领导范儿应助啦啦啦采纳,获得10
2秒前
katarinabluu完成签到,获得积分10
3秒前
彭于晏应助leanne采纳,获得10
3秒前
我是老大应助明道若昧采纳,获得10
3秒前
sssyq发布了新的文献求助10
3秒前
着急的觅海完成签到,获得积分10
3秒前
4秒前
ylky发布了新的文献求助10
9秒前
科研通AI2S应助浮浮世世采纳,获得10
9秒前
传奇3应助华中科技大学采纳,获得10
9秒前
情怀应助WN采纳,获得10
10秒前
10秒前
13秒前
朴实山兰完成签到,获得积分10
15秒前
17秒前
SciGPT应助ylky采纳,获得10
17秒前
小爪冰凉发布了新的文献求助10
17秒前
18秒前
量子星尘发布了新的文献求助10
18秒前
JamesPei应助科研小牛采纳,获得150
19秒前
Ava应助科研小牛采纳,获得10
19秒前
19秒前
忧郁盼夏发布了新的文献求助10
22秒前
marina关注了科研通微信公众号
22秒前
沐紫心完成签到 ,获得积分10
23秒前
科研通AI5应助suger采纳,获得10
23秒前
25秒前
八九发布了新的文献求助10
25秒前
28秒前
28秒前
一个好听的名字完成签到,获得积分10
29秒前
wbh发布了新的文献求助20
29秒前
29秒前
30秒前
Eddoes完成签到,获得积分10
30秒前
WN发布了新的文献求助10
31秒前
诚心的凌旋完成签到,获得积分10
31秒前
leanne发布了新的文献求助10
33秒前
机智思真完成签到,获得积分10
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173